{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:08:59Z","timestamp":1792696139993,"version":"4.5.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,13]]},"DOI":"10.7759\/cureus.38986","type":"journal-article","created":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T06:43:01Z","timestamp":1684046581000},"source":"Crossref","is-referenced-by-count":6,"title":["Alopecia Areata After Initiation of Secukinumab Therapy for Plaque Psoriasis"],"prefix":"10.7759","author":[{"given":"Esther","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths CEM","year":"2021","unstructured":"Griffiths CEM, Armstrong AW, Gudjonsson JE, Barker JN. Psoriasis. Lancet. 2021, 397:1301-15. 10.1016\/S0140-6736(20)32549-6","journal-title":"Lancet"},{"key":"ref2","article-title":"Alopecia areata: part 1: pathogenesis, diagnosis, and prognosis","volume":"61","author":"Spano F","year":"2015","unstructured":"Spano F, Donovan JC. Alopecia areata: part 1: pathogenesis, diagnosis, and prognosis. Can Fam Physician. 2015, 61:751-5.","journal-title":"Can Fam Physician"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon A","year":"2019","unstructured":"Rendon A, Sch\u00e4kel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019, 20:1475. 10.3390\/ijms20061475","journal-title":"Int J Mol Sci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14775","article-title":"Role of T helper 17 cells and T regulatory cells in alopecia areata: comparison of lesion and serum cytokine between controls and patients","volume":"32","author":"Loh SH","year":"2018","unstructured":"Loh SH, Moon HN, Lew BL, Sim WY. Role of T helper 17 cells and T regulatory cells in alopecia areata: comparison of lesion and serum cytokine between controls and patients. J Eur Acad Dermatol Venereol. 2018, 32:1028-33. 10.1111\/jdv.14775","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.03.024","article-title":"Secukinumab long-term safety experience: a pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis","volume":"75","author":"van de Kerkhof PC","year":"2016","unstructured":"van de Kerkhof PC, Griffiths CE, Reich K, et al.. Secukinumab long-term safety experience: a pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis. J Am Acad Dermatol. 2016, 75:83-98.e4. 10.1016\/j.jaad.2016.03.024","journal-title":"J Am Acad Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000478072","article-title":"Adverse reactions to biologics in psoriasis","volume":"53","author":"Lockwood SJ","year":"2018","unstructured":"Lockwood SJ, Prens LM, Kimball AB. Adverse reactions to biologics in psoriasis. Curr Probl Dermatol. 2018, 53:1-14. 10.1159\/000478072","journal-title":"Curr Probl Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-018-1823-y","article-title":"IL-17 inhibition: is it the long-awaited savior for alopecia areata?","volume":"310","author":"Ramot Y","year":"2018","unstructured":"Ramot Y, Marzani B, Pinto D, Sorbellini E, Rinaldi F. IL-17 inhibition: is it the long-awaited savior for alopecia areata?. Arch Dermatol Res. 2018, 310:383-90. 10.1007\/s00403-018-1823-y","journal-title":"Arch Dermatol Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-018-1853-5","article-title":"Efficacy and safety of secukinumab treatment in adults with extensive alopecia areata","volume":"310","author":"Guttman-Yassky E","year":"2018","unstructured":"Guttman-Yassky E, Nia JK, Hashim PW, et al.. Efficacy and safety of secukinumab treatment in adults with extensive alopecia areata. Arch Dermatol Res. 2018, 310:607-14. 10.1007\/s00403-018-1853-5","journal-title":"Arch Dermatol Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000499030","article-title":"Alopecia diffusa while using interleukin-17 inhibitors against psoriasis vulgaris","volume":"11","author":"Yajima M","year":"2019","unstructured":"Yajima M, Akeda T, Kondo M, Habe K, Yamanaka K. Alopecia diffusa while using interleukin-17 inhibitors against psoriasis vulgaris. Case Rep Dermatol. 2019, 11:82-5. 10.1159\/000499030","journal-title":"Case Rep Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2019.10.012","article-title":"Ixekizumab-induced alopecia areata","volume":"6","author":"Eldirany SA","year":"2020","unstructured":"Eldirany SA, Myung P, Bunick CG. Ixekizumab-induced alopecia areata. JAAD Case Rep. 2020, 6:51-3. 10.1016\/j.jdcr.2019.10.012","journal-title":"JAAD Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-017-0296-7","article-title":"Clinical signs, pathophysiology and management of cutaneous side effects of anti-tumor necrosis factor agents","volume":"18","author":"Segaert S","year":"2017","unstructured":"Segaert S, Hermans C. Clinical signs, pathophysiology and management of cutaneous side effects of anti-tumor necrosis factor agents. Am J Clin Dermatol. 2017, 18:771-87. 10.1007\/s40257-017-0296-7","journal-title":"Am J Clin Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2018.12.001","article-title":"Alopecia areata: a multifactorial autoimmune condition","volume":"98","author":"Simakou T","year":"2019","unstructured":"Simakou T, Butcher JP, Reid S, Henriquez FL. Alopecia areata: a multifactorial autoimmune condition. J Autoimmun. 2019, 98:74-85. 10.1016\/j.jaut.2018.12.001","journal-title":"J Autoimmun"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/115340-alopecia-areata-after-initiation-of-secukinumab-therapy-for-plaque-psoriasis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:59:43Z","timestamp":1707508783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/115340-alopecia-areata-after-initiation-of-secukinumab-therapy-for-plaque-psoriasis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,13]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.38986","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,13]]}}}